Reimagining Aging: Trials and Tribulations

This chapter explores the complexities of clinical trial protocols in Alzheimer's treatment, emphasizing the debate between prevention and reversal of cognitive decline. It raises important philosophical questions regarding healthspan versus lifespan and critiques societal attitudes towards aging and longevity. The discussion extends to the potential of partial reprogramming therapies and the necessity of innovative approaches in aging research for successful clinical outcomes.